May 14, 2025 18:00
ATRC - AtriCure, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
35.64 1.39 (3.9%) | --- | --- | --- | --- | 1.39 (3.9%) | --- | --- |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Earnings & Ratios
- Basic EPS:
- -0.13
- Diluted EPS:
- -0.13
- Basic P/E:
- -284.8385
- Diluted P/E:
- -284.8385
- RSI(14) 1m:
- 71.7
- VWAP:
- 36.97
- RVol:
- 0.8417
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 36.67 +0.41 (+1.14%) | Oct 15 09:46 |
Related News
Jul 23, 2024 18:08
May 02, 2024 12:01
May 02, 2024 00:00
May 01, 2024 21:30
Apr 19, 2024 13:45
Apr 10, 2024 12:01
Feb 16, 2024 13:30
Feb 16, 2024 12:00
Feb 16, 2024 00:00